American Century Companies Inc. Acquires 1,500,485 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

American Century Companies Inc. increased its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 628.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,739,323 shares of the company's stock after purchasing an additional 1,500,485 shares during the period. American Century Companies Inc. owned approximately 2.03% of Pediatrix Medical Group worth $22,820,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. State Street Corp increased its holdings in Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company's stock valued at $41,038,000 after buying an additional 50,597 shares during the period. Pacer Advisors Inc. acquired a new stake in shares of Pediatrix Medical Group during the 4th quarter worth approximately $35,492,000. Boston Partners boosted its position in shares of Pediatrix Medical Group by 25.2% during the 4th quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after acquiring an additional 393,600 shares in the last quarter. Geode Capital Management LLC increased its stake in Pediatrix Medical Group by 2.4% in the third quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company's stock valued at $22,452,000 after acquiring an additional 45,155 shares during the last quarter. Finally, Weiss Asset Management LP raised its position in Pediatrix Medical Group by 50.5% during the third quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock valued at $10,580,000 after purchasing an additional 306,143 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Wall Street Analyst Weigh In

MD has been the topic of several recent analyst reports. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Macquarie assumed coverage on Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 target price for the company. Truist Financial increased their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a report on Friday, February 21st. Finally, UBS Group lifted their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 4.5 %

Shares of Pediatrix Medical Group stock traded down $0.67 on Thursday, hitting $14.15. The stock had a trading volume of 549,655 shares, compared to its average volume of 835,067. The stock has a 50 day moving average of $14.44 and a 200 day moving average of $13.75. The firm has a market capitalization of $1.21 billion, a P/E ratio of -11.79, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.12. The firm had revenue of $502.36 million during the quarter, compared to analysts' expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.